ZTS
$155.24
Zoetis Inc Cl A
ZTS
Earnings Whisper ®
N/A
1st Quarter March 2021
Consensus:  $1.03
Revenue:  $1.73 Bil
Tuesday
May 18
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Tuesday, February 16, 2021

What do you expect when ZTS reports earnings?
Beat
Meet
Miss

Where is ZTS's stock price going from here?
Up
Flat
Down
Stock chart of ZTS
Analysts
Summary of analysts' recommendations for ZTS
Score
Grade
Pivots
Resistance
$159.33
$158.39
$156.82

$155.88

Support
$154.31
$153.37
$151.80
Tweet
Growth
Description
Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.
Peers
InterCeptVertex PharmaceuticalsRegeneron PharmaceuticalsBioMarin PharmaceuticalBristol-Myers SquibbPfizerMerck & Co.Johnson & JohnsonUltragenyx PharmaceuticalEli Lilly